APA (7th ed.) Citation

Liang, X., & Xia, R. (2022). Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia. Oncology reports, 47(1), 1. https://doi.org/10.3892/ar.2021.8229

Chicago Style (17th ed.) Citation

Liang, Xinglin, and Ruixiang Xia. "Kinesin Family Member 2A Acts as a Potential Prognostic Marker and Treatment Target via Interaction with PI3K/AKT and RhoA/ROCK Pathways in Acute Myeloid Leukemia." Oncology Reports 47, no. 1 (2022): 1. https://doi.org/10.3892/ar.2021.8229.

MLA (9th ed.) Citation

Liang, Xinglin, and Ruixiang Xia. "Kinesin Family Member 2A Acts as a Potential Prognostic Marker and Treatment Target via Interaction with PI3K/AKT and RhoA/ROCK Pathways in Acute Myeloid Leukemia." Oncology Reports, vol. 47, no. 1, 2022, p. 1, https://doi.org/10.3892/ar.2021.8229.